Literature DB >> 10473180

In vitro evaluation of the amebicidal activity of Buddleia cordata (Loganiaceae, H.B.K.) on several strains of Acanthamoeba.

S Rodríguez-Zaragoza1, C Ordaz, G Avila, J L Muñoz, A Arciniegas, A Romo de Vivar.   

Abstract

Infectious diseases produced by free-living amoebae from the genus Acanthamoeba have been recently recognized. The need for antiamebic compounds is urgent as the occurrence of these diseases is being registered more frequently since the late sixties. We screened the aqueous and methanolic extract of a plant used by folk medicine (Buddleia cordata) against eye and skin inflammation for antiamebic activity. We tested the extracts on 29 strains of free-living amoebae, with the result that they were amebostatic for 14 and 15 strains, respectively. We obtained linarin and vanillic acid from the extracts, but only linarin was amebostatic to all the strains and vanillic acid had no activity. However, acetyl vanillic acid had similar effects on amoebae to linarin. Threshold values of these two active compounds ranged from 31.25 microg/ml to 4 mg/ml and from 31.25 microg/ml to 8 mg/ml for linarin and acetyl vanillic acid, respectively. These differences in threshold values were observed even on several strains belonging to the same species (as in the case of A. castellanii and A. polyphaga) indicating the need of susceptibility testing for each clinical isolate of free-living amoebae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473180     DOI: 10.1016/s0378-8741(98)00186-x

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model.

Authors:  Gabriela Pérez-Barrón; José Guillermo Avila-Acevedo; Ana María García-Bores; Sergio Montes; Sara García-Jiménez; Ismael León-Rivera; Moisés Rubio-Osornio; Antonio Monroy-Noyola
Journal:  J Nat Med       Date:  2014-09-25       Impact factor: 2.343

Review 2.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

3.  Artemisia annua L. as a plant with potential use in the treatment of acanthamoebiasis.

Authors:  Monika Derda; Edward Hadaś; Marcin Cholewiński; Łukasz Skrzypczak; Anna Grzondziel; Agnieszka Wojtkowiak-Giera
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

4.  A Review of the Current Research Trends in the Application of Medicinal Plants as a Source for Novel Therapeutic Agents Against Acanthamoeba Infections.

Authors:  Maryam Niyyati; Samira Dodangeh; Jacob Lorenzo-Morales
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Amebicidal effects of fenugreek (Trigonella foenum-graecum) against Acanthamoeba cysts.

Authors:  Yasemin Kaya; Ayşe Baldemir; Ülkü Karaman; Nilay Ildız; Yeliz Kasko Arıcı; Gamze Kaçmaz; Zeynep Kolören; Yusuf Konca
Journal:  Food Sci Nutr       Date:  2019-01-28       Impact factor: 2.863

6.  Phytochemical Screening and Acanthamoebic Activity of Shoots from in Vitro Cultures and in Vivo Plants of Eryngium alpinum L.-The Endangered and Protected Species.

Authors:  Małgorzata Kikowska; Dariusz Kruszka; Monika Derda; Edward Hadaś; Barbara Thiem
Journal:  Molecules       Date:  2020-03-20       Impact factor: 4.411

7.  PLGA nanoparticles loaded with Gallic acid- a constituent of Leea indica against Acanthamoeba triangularis.

Authors:  Tooba Mahboob; Muhammad Nawaz; Maria de Lourdes Pereira; Tan Tian-Chye; Chandramathi Samudi; Shamala Devi Sekaran; Christophe Wiart; Veeranoot Nissapatorn
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

8.  The Evaluation of Phenolic Acids and Flavonoids Content and Antiprotozoal Activity of Eryngium Species Biomass Produced by Biotechnological Methods.

Authors:  Małgorzata Kikowska; Justyna Chanaj-Kaczmarek; Monika Derda; Anna Budzianowska; Barbara Thiem; Halina Ekiert; Agnieszka Szopa
Journal:  Molecules       Date:  2022-01-07       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.